Original articles, written in-house and citing our sources, on news relevant to Atumio's active case types.
The first Camp Lejeune Justice Act trial began October 26, 2026 in federal court in Elizabeth City, N.C. — a bench trial over former Marine Frank Mousser's kidney cancer claim. It comes as plaintiffs' leadership proposed a 25-disease claimant census, the government asked for a Lone Pine evidence order, and an October 30 settlement-framework deadline approaches.
Read more →MinterEllison filed a class action in Australia's Federal Court on October 9, 2026, on behalf of children and teens allegedly harmed by addictive design features and harmful content on Facebook and Instagram. The case is funded by Litigation Lending Services; Meta says it will defend itself. It adds an international front to the social media addiction litigation already underway in the U.S.
Read more →An Ohio state jury returned a verdict for Johnson & Johnson on October 23, 2026 in a wrongful death suit brought by the family of a woman who alleged her mesothelioma came from years of using asbestos-contaminated talc cosmetic products. The defense win follows several large plaintiff verdicts against J&J in 2026, as the company litigates its remaining talc cases one at a time.
Read more →At a Greenville, N.C., rally, President Trump tied fast settlement of remaining Camp Lejeune Justice Act claims to Republicans holding Congress in the midterms. Advocates and lawmakers objected, and attorneys noted payouts come from the permanent federal Judgment Fund, as the first trials begin in Elizabeth City.
Read more →The U.S. Supreme Court on October 5 declined to hear an appeal from the estates of two Libby, Montana mesothelioma victims, leaving intact a Ninth Circuit decision that overturned their combined $8 million jury award against BNSF under Montana's common-carrier exception to strict liability.
Read more →On October 1, 2026, Chief Judge Richard Myers denied a motion challenging how the DOJ calculated a Camp Lejeune Elective Option offer, holding that program-wide disputes belong on the master docket. The court did not decide whether the offers were calculated correctly.
Read more →Judge Vince Chhabria has invited amicus briefs on whether the Supreme Court's June 2026 Monsanto v. Durnell decision also preempts negligence, design defect and warranty claims in six states, a question that could decide the fate of many remaining federal Roundup cases.
Read more →The Social Security Administration announced a 3.6% cost-of-living adjustment for 2027, raising the average SSDI check by about $59 a month and lifting the substantial gainful activity and trial work period earnings limits.
Read more →Fifteen states and Guam sued in Indiana on October 1, 2026, alleging the Vylor seed spinoff moved about $40 billion in assets out of reach of DuPont's historical PFAS liabilities.
Read more →Four men from Pennsylvania, North Dakota, Connecticut and Delaware filed suit in Delaware Superior Court on September 15, 2026, alleging that years of exposure to the insecticide chlorpyrifos caused their Parkinson's disease. It is one of only a handful of chlorpyrifos Parkinson's cases filed so far.
Read more →After overriding former Mayor Eric Adams's veto in January 2026, the New York City Council reopened a temporary window under the city's Gender-Motivated Violence Act. Survivors of older abuse can sue both the abuser and any institution that enabled it, including city jails and juvenile detention centers, until the window closes in 2027.
Read more →A federal judge in Idaho dismissed former NFL player Merril Hoge's Roundup failure-to-warn claim in light of the Supreme Court's preemption ruling, but let his negligence and design-defect claims proceed toward a jury.
Read more →In a September 29, 2026 order, the four judges overseeing the Camp Lejeune litigation reappointed the Plaintiffs' Leadership Group through October 30, 2027, finding progress toward a global settlement while keeping the October 30, 2026 settlement target and weekly settlement-master meetings in place.
Read more →Uber settled the third federal bellwether case in the rideshare sexual assault MDL on October 2, 2026, after a jury had been picked but before opening statements, breaking from its approach of taking the first two bellwethers to verdict.
Read more →A St. Louis jury began hearing the first Roundup trial since the Supreme Court's June 2026 ruling for Bayer, as three women outside the proposed $7.25 billion settlement press design-defect claims while the settlement still awaits a judge's decision.
Read more →U.S. District Judge Terrence Boyle set the first two Camp Lejeune water contamination cases for non-jury trials on November 9 and November 16, 2026, both involving kidney cancer, with the science linking that cancer to the base's water expected to be the central fight.
Read more →The next trial in California's coordinated social media addiction proceeding opens October 28, 2026, with two plaintiffs, S.J. and K.D.B., facing Meta, YouTube, and Snap before a single Los Angeles jury after TikTok settled and a third plaintiff dropped out.
Read more →Los Angeles Superior Court Judge Carolyn Kuhl rejected Meta's motion to quash subpoenas for Mark Zuckerberg and Adam Mosseri, who are now expected to testify at the consolidated social media addiction trial against Meta, YouTube, and Snap beginning October 28, 2026.
Read more →In a September 15, 2026 order, Judge David Novak confirmed Hopeman Brothers' Chapter 11 plan, establishing a Section 524(g) trust — funded largely by roughly $50 million in insurer payments — to handle current and future asbestos injury claims tied to its shipbuilding work.
Read more →A Dedham, Massachusetts man has sued Novo Nordisk alleging Ozempic caused NAION and permanent vision loss in both eyes; his case joins the federal GLP-1 vision-loss MDL, which had 216 pending cases as of September 1, 2026.
Read more →Johnson & Johnson settled with the families of three women whose Los Angeles ovarian cancer bellwether trial ended in a 10-2 defense verdict, ending the families' post-trial challenge to that verdict.
Read more →Asbestos claimants in the DBMP LLC bankruptcy, a CertainTeed spinoff created through a Texas divisional merger, have petitioned the U.S. Supreme Court to review a 2-1 Fourth Circuit ruling that kept their lawsuits frozen.
Read more →Judge M. Casey Rodgers appointed Matt Garretson as allocation master and CPA Randall Sansom as fund administrator for Pfizer's Depo-Provera settlement, and federal plaintiffs must register by November 30, 2026, with first payments expected in early 2027.
Read more →The third Bard PowerPort bellwether trial — May Lattanzio's infection and sepsis claim — is set to start October 13, 2026 before Judge David G. Campbell in Arizona, following a defense verdict in the first infection trial and a $40 million plaintiff verdict in the second.
Read more →Tennessee's Williamson County Chancery Court denied Roblox's motion to dismiss the state's consumer protection lawsuit, announced September 22, 2026, finding the case targets Roblox's own safety promises rather than user content.
Read more →Parties in the federal Dupixent T-cell lymphoma MDL filed a joint case management report on September 10, 2026 ahead of an October 1 conference, as a Louisiana man's new lawsuit against Regeneron and Sanofi adds to the growing case count.
Read more →Governor Newsom signed a package of California laws targeting addictive social media feeds and AI companion chatbots aimed at minors, including 'Adam's Law' requiring crisis protocols and safety audits for chatbot makers.
Read more →A federal jury in Illinois cleared Mead Johnson on September 1, 2026 in the first bellwether trial to reach a verdict in the NEC baby formula MDL, a defense win in a case involving a premature infant's death.
Read more →Six Camp Lejeune Elective Option claimants say the government miscalculated their settlement offers using the wrong exposure-time category. The DOJ says courts can't review the offers, and they expire September 27.
Read more →A New Orleans jury found J&J's talc products caused a woman's fatal mesothelioma, awarding her family $10 million and setting J&J's individual liability share at just over $1.2 million.
Read more →A divided Ninth Circuit panel ruled on September 3, 2026 that Roblox waived its right to force a child-safety class action into arbitration by litigating the case's merits for nearly a year before invoking arbitration.
Read more →Rep. Carol Miller introduced a House companion to the bipartisan We Can't Wait Act on September 2, 2026, which would let approved SSDI recipients elect to start benefits immediately instead of waiting five months.
Read more →A Missouri judge heard arguments for and against Bayer's $7.25 billion Roundup settlement on September 14, 2026, covering roughly 65,000 claims, but did not rule from the bench.
Read more →A four-judge panel has ordered the DOJ and plaintiffs' leadership to reach a global Camp Lejeune settlement by October 30, 2026, tying the deadline to attorney reappointments and the threat of court sanctions.
Read more →The CDC says the Cyclospora outbreak tied to Taylor Farms iceberg lettuce has ended, with a final count of 12,883 illnesses, 570 hospitalizations, and 2 deaths across 21 states.
Read more →A federal panel will hear arguments September 24, 2026 on whether to centralize Nevro spinal cord stimulator injury lawsuits into a new MDL, over the manufacturer's objection that the cases lack common defect and injury allegations.
Read more →A Baltimore jury awarded $1.56 billion on December 22, 2025 to a Maryland woman with mesothelioma linked to decades of J&J talc-based baby powder use, the largest single-plaintiff verdict in the litigation to date.
Read more →GSK reached settlement agreements worth up to $2.2 billion covering roughly 80,000 state-court Zantac cancer lawsuits, about 93% of pending state cases against the company, announced October 9, 2024.
Read more →A federal jury in Arizona awarded Kimberly Divelbliss $40 million on September 4, 2026, finding Bard's PowerPort catheter defectively designed — the first plaintiff win in the five-case PowerPort bellwether program.
Read more →North Carolina's Attorney General announced a $590 million settlement with DuPont, Chemours, and Corteva on September 10, 2026, over PFAS pollution from the Fayetteville Works plant — the largest environmental damages recovery in state history.
Read more →A Los Angeles Superior Court judge denied Roblox's anti-SLAPP motion and motion to dismiss on September 1, 2026, in LA County's child safety lawsuit, clearing the case to move toward the merits.
Read more →The FDA told Judge Cote on September 8, 2026 that it won't take a position on a proposed pregnancy warning label for Tylenol, resubmitting a 2023 literature review instead — and the judge kept the case's Daubert deadline intact after defendants sought a status conference.
Read more →Abbott agreed in late August 2026 to pay $670 million to resolve roughly 2,000 claims that its preterm infant formula caused necrotizing enterocolitis, though about 1,700 lawsuits covering 12,700 infants remain pending against the company.
Read more →A coalition of 51 state attorneys general reached a settlement worth up to $17.1 billion with Meta on August 26, 2026, reached mid-trial, requiring new youth-safety features on Facebook and Instagram.
Read more →The judge overseeing the Boston Scientific spinal cord stimulator MDL entered Pretrial Order No. 4 on August 18, 2026, letting new plaintiffs file directly into the federal court in California instead of first filing in their home district.
Read more →Walmart agreed to pay $50 million and adopt new pharmacy safeguards to resolve a six-year-old Justice Department lawsuit accusing its pharmacies of illegally filling invalid opioid prescriptions since 2013.
Read more →The 9th Circuit ruled on August 10, 2026 that Meta, Google, TikTok, and Snap can't use Section 230 to block appeal of a lower-court order, clearing more than 3,000 social media addiction lawsuits to proceed.
Read more →Nearly 2,000 Lyft passenger sexual assault cases are coordinated in California state court, with the first bellwether trial set for September 30, 2026 — a separate track from the roughly 4,400 similar lawsuits pending against Uber.
Read more →Senators Hawley and Durbin opened a formal child-safety investigation into Roblox in mid-August 2026, the same week Ohio's attorney general moved to lead a securities class action alleging the company misled investors about its safety measures.
Read more →A Chicago couple filed the first Illinois lawsuit over the 2026 Cyclospora lettuce outbreak on August 21, 2026, as the CDC and FDA put the nationwide case count at 10,930 illnesses across 17 states, with 454 hospitalizations and two deaths.
Read more →A St. Louis jury ruled for Mead Johnson on July 6, 2026 in a state-court trial over whether its Enfamil preterm formula caused an infant's necrotizing enterocolitis, a defense win as nearly 1,000 similar cases move through state and federal courts.
Read more →Vi-Jon, maker of store-brand body powders sold by major retailers, filed Chapter 11 bankruptcy in Delaware on August 2, 2026 to resolve over $700 million in talc-related mesothelioma and lung cancer claims.
Read more →Families are suing AI chatbot makers including Character.AI, Google, and OpenAI over deaths and injuries linked to chatbot interactions, and Florida has filed the first state lawsuit against OpenAI.
Read more →Washington's Attorney General opened trial against Albertsons on July 13, 2026, alleging its pharmacies dispensed more than 641 million opioid pills despite unresolved red flags between 2006 and 2022.
Read more →Federal juries sided with plaintiffs in both Uber passenger sexual assault bellwether trials held so far in 2026, and a judge ruled Uber is a common carrier, ahead of the next trials set for September.
Read more →The JPML created MDL No. 3181 for Boston Scientific spinal cord stimulator lawsuits on June 5, 2026, centralizing 23 device-failure cases in the Central District of California.
Read more →The JPML centralized ByHeart infant formula botulism lawsuits into MDL No. 3178 in the Southern District of New York on April 2, 2026, following a nationwide recall tied to an infant botulism outbreak.
Read more →Camp Lejeune settlement offers have surpassed $1 billion and payouts have topped $827 million, as the DOJ approved $175 million in new settlements over a recent three-week stretch.
Read more →The first federal bellwether trial against Mead Johnson's Enfamil opened August 12, 2026, the start of a second wave of NEC baby formula trials scheduled through early 2027.
Read more →The Judicial Panel on Multidistrict Litigation centralized federal Dupixent T-cell lymphoma lawsuits into MDL No. 3180 in New Jersey on June 4, 2026, consolidating 15 transferred cases before Judge Zahid N. Quraishi.
Read more →Chief Judge Renée Marie Bumb gave final approval on August 7, 2026 to more than $2.5 billion in New Jersey PFAS settlements with DuPont, Chemours, Corteva, and 3M, including a $1.2 billion restoration fund.
Read more →The JPML created MDL No. 3196 on August 1, 2026 for lawsuits over a Cyclospora outbreak traced to Taylor Farms iceberg lettuce, which the CDC says has sickened more than 6,300 people across 15 states.
Read more →The SSA added 14 new conditions to its Compassionate Allowances list on August 11, 2026, letting people with those diagnoses get SSDI decisions faster.
Read more →A New Mexico judge ordered Meta to pay $567 million into a youth mental health treatment and prevention fund on August 6, 2026, bringing the company's total exposure in the state's case to $942 million.
Read more →The California Supreme Court ruled 6-1 on August 3, 2026 that Gilead owed no duty to speed a safer HIV drug to market, resolving one theory in the Gilead Tenofovir Cases while separate failure-to-warn claims from roughly 26,000 TDF/Truvada plaintiffs continue.
Read more →Uniroyal Holding and its Great Hill Corporation subsidiary filed Chapter 11 bankruptcy on July 31, 2026 in New Jersey to resolve more than 35,000 pending asbestos injury claims through a negotiated trust plan.
Read more →A catheter-fracture case survived summary judgment on July 27, 2026 and is set to become the second Bard PowerPort MDL bellwether trial, beginning August 18, 2026, after the first trial ended in a split verdict.
Read more →A Missouri court delayed the final approval hearing for Bayer's $7.25 billion Roundup settlement to September 14, giving more time to resolve opt-out disputes.
Read more →A federal jury in Boston ordered Medtronic to pay $88 million on August 4, 2026 over its Covidien unit's Symbotex hernia mesh, the largest verdict yet in the hernia mesh litigation and the outcome of the first Covidien bellwether trial.
Read more →A Cook County jury awarded $53 million in compensatory damages, plus $17 million in punitive damages, on April 9, 2026 to four mothers whose premature infants developed NEC after being fed Abbott's Similac Special Care 24 formula.
Read more →Johnson & Johnson has proposed a $5.5 billion settlement to resolve roughly 76,000 remaining talcum powder lawsuits, its fourth attempt to close out the litigation after three failed bankruptcy maneuvers.
Read more →A new case management order in the federal paraquat MDL requires plaintiffs who didn't accept the settlement offer to produce detailed proof of exposure, diagnosis, and causation, or risk dismissal.
Read more →The D.C. Court of Appeals denied Meta's attempt to shield internal youth-wellbeing research from discovery in a consumer-protection lawsuit, letting document production continue.
Read more →A Delaware court dismissed more than 80,000 Zantac cancer lawsuits against Boehringer Ingelheim in April 2026 over expert testimony standards — but cases against other manufacturers, and in other states, are still moving forward.
Read more →A Missouri appeals court upheld a $495 million jury verdict against Abbott Laboratories in a preterm infant formula NEC case, rejecting the company's bid to overturn the award and clearing the way for a possible Missouri Supreme Court appeal.
Read more →The Social Security Administration marked SSDI's 70th anniversary on August 1, 2026, reporting initial disability decisions now arrive 40 days faster than in January 2025.
Read more →A Missouri judge set August 19, 2026 as the new final approval hearing date for Bayer's $7.25 billion Roundup class settlement, following objections and a favorable Supreme Court ruling for Bayer.
Read more →A California jury awarded $966 million to the family of an 88-year-old woman who died of mesothelioma linked to decades of Johnson & Johnson talc-based baby powder use.
Read more →A New Mexico jury found Meta misled users about platform safety and put children at risk, ordering the company to pay $375 million — a separate verdict from the March 2026 Meta/YouTube case.
Read more →The federal paraquat MDL has paused individual case preparations while the court considers approving a Qualified Settlement Fund — a concrete step toward actually distributing settlement money.
Read more →DuPont agreed to pay $27 million to resolve nearly a decade of litigation over PFOA water contamination in Hoosick Falls, New York, linked to a nearby Teflon manufacturing site.
Read more →The first federal Enfamil bellwether trial began July 6, 2026, brought by a father whose son died days after birth — a pivotal early test of how juries respond to the NEC baby formula claims.
Read more →The Social Security Administration announced new self-service tools on July 21, 2026 — including a Claim Status Tracker and online document submission — aimed at giving SSDI applicants more visibility into their case.
Read more →A Texas judge rejected Kenvue's motion to dismiss Attorney General Ken Paxton's consumer-protection lawsuit over Tylenol's autism warnings — a separate legal track from the federal personal-injury MDL.
Read more →California, Colorado, Kentucky, and New Jersey are set to try their case against Meta on August 12, 2026, seeking massive civil penalties over allegedly addictive platform design aimed at kids.
Read more →Vermont signed a first-in-the-nation ban on the herbicide paraquat into law on May 26, 2026, citing mounting scientific evidence and thousands of pending Parkinson's disease lawsuits.
Read more →In December 2025, the FDA approved new label language warning that Depo-Provera use is linked to meningioma brain tumors, reversing an earlier decision that had rejected Pfizer's own request for the warning in 2024.
Read more →In February 2025, the federal judicial panel consolidated Depo-Provera meningioma lawsuits into a new multidistrict litigation in Florida, and filings have grown from 27 cases to thousands within about a year.
Read more →After falling from about 350,000 to roughly 270,000 pending hearings in early 2025, the Social Security Administration's disability hearing backlog has climbed back to about 330,000 cases in 2026, extending wait times for claimants.
Read more →The 2026 Substantial Gainful Activity limit, Trial Work Period threshold, and work-credit earnings requirement all increased this year, and a new law expanded ABLE savings account eligibility to millions more disabled Americans.
Read more →The Social Security Administration's 2.8% cost-of-living adjustment took effect in January 2026, raising the average SSDI payment by about $44 a month, though a rising Medicare Part B premium offsets some of that gain for many beneficiaries.
Read more →The first bellwether trial against Covidien over its Symbotex hernia mesh began July 13, 2026 in Boston after a federal judge rejected the company's request to throw out the case, testing claims from more than 2,200 consolidated lawsuits.
Read more →Becton Dickinson's 2024 hernia mesh settlement set up a points-based payout system, but portal problems and a multi-year distribution timeline mean many of the roughly 38,000 claimants are still waiting to get paid in 2026.
Read more →Becton Dickinson announced in October 2024 it would pay more than $1 billion to resolve over 38,000 lawsuits alleging its Bard and Davol hernia mesh products caused organ damage and chronic pain, a deal still shaping the litigation landscape in 2026.
Read more →Bayer's proposed $7.25 billion Roundup class settlement headed to a July 9, 2026 fairness hearing facing more than 100 objections over its opt-out process, attorney fees, and a novel future-claimants subclass.
Read more →In a 7-2 ruling in Monsanto Co. v. Durnell, the Supreme Court held federal pesticide law preempts state failure-to-warn claims requiring a cancer warning EPA hasn't approved — reshaping the landscape for pending Roundup lawsuits.
Read more →A Cobb County, Georgia jury ordered Bayer's Monsanto unit to pay $2.1 billion, including $2 billion in punitive damages, to a man who developed non-Hodgkin lymphoma after two decades of Roundup use.
Read more →A December 2024 dismissal by a federal judge sidelined more than 500 Tylenol autism/ADHD lawsuits for over a year and a half. Here's what that ruling said and why it mattered.
Read more →The Second Circuit has reversed a ruling that gutted the federal Tylenol autism/ADHD litigation, reviving more than 500 cases. Here's what the decision means and what happens next.
Read more →The FDA moved to add an autism/ADHD warning to acetaminophen labels in September 2025. Kenvue's most recent label update, in May 2026, still doesn't include one. Here's the timeline.
Read more →Chemours has agreed to a $450 million settlement with the DOJ and EPA over Clean Water Act violations at three PFAS-producing plants — the first federal enforcement settlement of its kind.
Read more →DuPont, Chemours, and Corteva agreed to pay New Jersey $875 million over 25 years to resolve PFAS contamination claims at four industrial sites, plus fund a remediation reserve of up to $1.2 billion.
Read more →A federal judge has approved agreements clearing the way for New Jersey's PFAS settlements with 3M and DuPont-affiliated companies to move forward, after counties and water authorities dropped objections.
Read more →A Florida teen dropped his social media addiction claims against Meta the day after Snap tentatively settled, canceling a second bellwether trial. Here's what it means for the broader litigation.
Read more →A Los Angeles jury found Meta and YouTube liable for a young woman's social media addiction and awarded $6 million, one of the first verdicts to hold platforms liable for design rather than content.
Read more →TikTok reached a confidential settlement in July 2026 with a plaintiff who alleged the platform's design fueled his social media addiction as a child, avoiding the second bellwether trial in the California litigation.
Read more →A federal judge ordered a special master to help paraquat Parkinson's plaintiffs evaluate settlement offers as the MDL's global settlement framework moves toward payouts.
Read more →Syngenta says it will cease global paraquat production by June 2026, closing its only active-ingredient plant, as advocacy groups tie the move to litigation and state bans.
Read more →Syngenta settled the first paraquat Parkinson's bellwether trial the night before opening statements in Philadelphia, avoiding a jury verdict on causation.
Read more →A new federal MDL now consolidates lawsuits claiming Ozempic and other GLP-1 drugs caused NAION, a rare form of sudden vision loss, in a track separate from existing gastroparesis claims.
Read more →The judge overseeing the Ozempic gastroparesis MDL ruled that claims must be backed by an objective gastric emptying study, not just reported symptoms, raising the evidentiary bar litigation-wide.
Read more →The FDA revised Ozempic's prescribing label in January 2025 to warn about severe gastrointestinal adverse reactions, though plaintiffs' attorneys say it still doesn't fully warn of gastroparesis risk.
Read more →The federal AFFF firefighting foam MDL has grown to more than 23,000 pending cases, but a global personal-injury settlement still hasn't materialized as of mid-2026.
Read more →The first AFFF personal-injury bellwether trial, set for October 2025, was postponed after the court uncovered a backlog of unfiled cases, triggering a filing window and a surge of new claims.
Read more →A federal court gave final approval in 2024 to 3M's up-to-$10.3 billion settlement with public water utilities over PFAS contamination linked to AFFF firefighting foam, a track separate from personal-injury claims.
Read more →The Camp Lejeune Justice Act's filing deadline closed on August 10, 2024, with over 500,000 claims already on file with the Navy. That backlog is still shaping how long claimants are waiting today.
Read more →A June 2026 update shows fewer than 2% of Camp Lejeune Elective Option claims with basic documentation have enough proof to reach the Department of Justice for approval. Here's what's causing the bottleneck.
Read more →A February 2026 court filing shows the court-appointed Camp Lejeune settlement masters held direct mediation sessions with the DOJ and are building a settlement matrix — but no dollar terms have been set yet.
Read more →A February 2026 case management order in the hair relaxer cancer MDL lays out a 90-day window for a deceased plaintiff's family or estate to formally take over her lawsuit. Here's how the process works.
Read more →A unanimous October 2025 Georgia Supreme Court ruling rejected a 'one and done' time-bar defense in a hair relaxer injury case, holding the state's 10-year statute of repose applies separately to each product sold.
Read more →On June 5, 2026, the federal judge overseeing the hair relaxer cancer MDL reappointed 38 plaintiffs' attorneys to leadership roles as the litigation, now covering thousands of women, moves toward bellwether trial selection.
Read more →In February 2024, the Judicial Panel on Multidistrict Litigation consolidated Suboxone film tooth decay lawsuits into MDL 3092 in the Northern District of Ohio — the foundational event behind today's growing litigation against Indivior.
Read more →In February 2026, the Suboxone MDL judge randomly selected 100 cases for a Core Discovery Pool that will be narrowed further ahead of the litigation's first bellwether trials. Here's how the process works.
Read more →In June 2026, the judge overseeing the Suboxone tooth decay MDL compelled outstanding record production and set a July 1, 2026 contempt hearing for non-compliant providers, as the case against Indivior tops 17,900 claims.
Read more →Pfizer has reached a tentative framework to resolve thousands of federal Depo-Provera meningioma lawsuits — but state court cases, including hundreds in Delaware, are on a separate track and unaffected by it.
Read more →Pfizer and plaintiffs' leadership signed a binding Master Settlement Agreement on July 21, 2026, expected to resolve about 80% of pending federal Depo-Provera meningioma cases.
Read more →